ATE259652T1 - Neuronale verwendungen des bmp-11 - Google Patents

Neuronale verwendungen des bmp-11

Info

Publication number
ATE259652T1
ATE259652T1 AT98957711T AT98957711T ATE259652T1 AT E259652 T1 ATE259652 T1 AT E259652T1 AT 98957711 T AT98957711 T AT 98957711T AT 98957711 T AT98957711 T AT 98957711T AT E259652 T1 ATE259652 T1 AT E259652T1
Authority
AT
Austria
Prior art keywords
proteins
bmp
useful
disclosed
neural
Prior art date
Application number
AT98957711T
Other languages
English (en)
Inventor
Anthony J Celeste
John M Wozney
Scott R Thies
Original Assignee
Inst Genetics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc
Application granted granted Critical
Publication of ATE259652T1 publication Critical patent/ATE259652T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
AT98957711T 1997-11-07 1998-11-06 Neuronale verwendungen des bmp-11 ATE259652T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96629797A 1997-11-07 1997-11-07
PCT/US1998/023827 WO1999024058A2 (en) 1997-11-07 1998-11-06 Neuronal uses of bmp-11

Publications (1)

Publication Number Publication Date
ATE259652T1 true ATE259652T1 (de) 2004-03-15

Family

ID=25511184

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98957711T ATE259652T1 (de) 1997-11-07 1998-11-06 Neuronale verwendungen des bmp-11

Country Status (10)

Country Link
EP (1) EP1028744B1 (de)
JP (1) JP2001522810A (de)
AT (1) ATE259652T1 (de)
AU (2) AU1276399A (de)
CA (1) CA2309538A1 (de)
DE (1) DE69821793T2 (de)
DK (1) DK1028744T3 (de)
ES (1) ES2213927T3 (de)
PT (1) PT1028744E (de)
WO (2) WO1999024057A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030104977A1 (en) * 2000-03-31 2003-06-05 Ugo Ripamonti Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
TWI329129B (en) 2001-02-08 2010-08-21 Wyeth Corp Modified and stabilized gdf propeptides and uses thereof
EP1406926A2 (de) * 2001-07-06 2004-04-14 Nsgene A/S Neue neurotrophe faktoren
US7320789B2 (en) 2001-09-26 2008-01-22 Wyeth Antibody inhibitors of GDF-8 and uses thereof
JP4429729B2 (ja) 2002-02-21 2010-03-10 ワイス エルエルシー Ｇａｓｐ１；フォリスタチンドメイン含有タンパク質
WO2003072714A2 (en) 2002-02-21 2003-09-04 Wyeth Follistatin domain containing proteins
US7261893B2 (en) 2002-10-22 2007-08-28 Wyeth Neutralizing antibodies against GDF-8 and uses therefor
US7591999B2 (en) 2003-03-04 2009-09-22 Mitsubishi Tanabe Pharma Corporation Powdery preparation for nasal administration
EP1635870A2 (de) 2003-06-02 2006-03-22 Wyeth Verwendung von myostatin (gdf8) inhibitoren in kombination mit kortikosteroiden zur behandlung neuromuskulärer erkrankungen
EP1951756B1 (de) 2005-10-06 2015-01-07 Eli Lilly And Company Anti-myostatin-antikörper
UA92504C2 (en) 2005-10-12 2010-11-10 Эли Лилли Энд Компани Anti-myostatin monoclonal antibody
PT2066695E (pt) 2006-09-05 2013-05-23 Lilly Co Eli Anticorpos anti-miostatina
EP4140497A1 (de) 2013-04-08 2023-03-01 President and Fellows of Harvard College Zusammensetzungen zum verjüngen von stammzellen der skelettmuskulatur
US20160220640A1 (en) * 2013-06-11 2016-08-04 The Brigham And Women's Hospital, Inc. Methods and compositions for increasing neurogenesis and angiogenesis
WO2015070076A2 (en) * 2013-11-08 2015-05-14 President And Fellows Of Harvard College Methods and compositions for rejuvenating neuromuscular junctions
IL301476A (en) 2016-01-06 2023-05-01 Harvard College Treatment with GDF11 prevents weight gain, improves glucose loading and reduces hepatosteatosis
WO2019144053A1 (en) * 2018-01-19 2019-07-25 President And Fellows Of Harward College Gdf11 variants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2161808C (en) * 1993-05-12 2008-08-05 Anthony J. Celeste Bmp-11 compositions
SE9302550D0 (sv) * 1993-07-30 1993-07-30 Ernst Hoerlin Powder inhaler
PT716610E (pt) * 1993-08-26 2006-08-31 Genetics Inst Llc Proteinas morfogeneticas dos ossos de seres humanos para utilizacao em regeneracao neural
ES2251721T3 (es) * 1994-07-08 2006-05-01 The Johns Hopkins University School Of Medicine Factor-11 de diferenciacion del crecimiento.

Also Published As

Publication number Publication date
DE69821793T2 (de) 2004-12-30
DE69821793D1 (de) 2004-03-25
ES2213927T3 (es) 2004-09-01
AU761940B2 (en) 2003-06-12
DK1028744T3 (da) 2004-06-21
EP1028744B1 (de) 2004-02-18
AU1390099A (en) 1999-05-31
EP1028744A2 (de) 2000-08-23
WO1999024057A2 (en) 1999-05-20
WO1999024058A3 (en) 1999-08-19
AU1276399A (en) 1999-05-31
CA2309538A1 (en) 1999-05-20
WO1999024058A2 (en) 1999-05-20
JP2001522810A (ja) 2001-11-20
PT1028744E (pt) 2004-06-30

Similar Documents

Publication Publication Date Title
DE69434875D1 (de) BMP-11 Zusammenstellungen
ATE259652T1 (de) Neuronale verwendungen des bmp-11
ATE265529T1 (de) Bmp-10 zusammensetzungen
DK0429570T3 (da) Osteoinducerende præparater
ATE328896T1 (de) Faktor viii vom schwein und hybriden
CA2265508A1 (en) Bone morphogenetic protein-16 (bmp-16) compositions
EE04221B1 (et) Östrogeeni kasutamine ravimi valmistamiseks füüsiliste seisundite raviks menopausijärgsetel isikutel
IL192078A0 (en) Recombinant ??-l-iduronidase,methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
DE69726884D1 (de) Menschliches sdf-5 protein und diesbezügliche zusammensetzungen
EP1420031A3 (de) Morphogenetisches Protein der Knochen, BMP-18, und deren Zusammensetzungen
DE69728415D1 (de) Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)
GR3033698T3 (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections.
NZ334762A (en) Human DNase I variants having binding affinity to actin
ATE349521T1 (de) Mit cd40 und traf interagierende proteine
MXPA02000801A (es) Homologo humano de polinucleotidos, nesp55 de proteina secretora de neuroendocrino bovino y usos el mismo relacionado con la obesidad.
ATE245438T1 (de) Verwendung von oligomerem matrixprotein aus knorpel zur behandlung von rheumatoider arthritis
DE69910608D1 (de) Neue therapeutische verwendung von 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin
MX9800507A (es) Ctla-8 humana y usos de proteinas relacionadas con la ctla-8.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1028744

Country of ref document: EP